undefined undefined
NaN.000
NaN.00%
Unity Software(U.US) reported fourth-quarter financial results after the market...
04-24 01:10
Intellia Therapeutics (NTLA) has provided an update. Intellia Therapeutics has ...
04-16 04:32
CRISPR gene editing technology has been heralded as a revolutionary breakthrough in drug development, enabling scientists to potentially cure genetic diseases by modifying the genes that cause them. T...
03-26 23:43
Intellia Therapeutics (NASDAQ:NTLA) is opting out of an agreement with Regeneron Pharmaceuticals (NASDAQ:REGN) to co-develop a factor IX gene editing therapy for hemophilia A and B, the biotechnology ...
03-23 00:40
Intellia Therapeutics (NTLA) has shared an update. Intellia Therapeutics has de...
03-22 21:42
文|胡香赟 编辑|海若镜 2023年年底,美国FDA接连批准了两款CRISPR/Cas9基因编辑疗法上市,分别为福泰制药/CRISPR Therapeutic...
03-14 17:24
Canaccord Genuity analyst Whitney Ijem maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and raises the price target from $72 to $73.
02-23 22:54
Intellia Therapeutics (NASDAQ:NTLA) reported quarterly losses of $(1.46) per share which missed the analyst consensus estimate of $(1.45) by 0.69 percent. This is a 4.29 percent decrease over losses of $(1.40) per share
02-22 20:36
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
02-22 18:27
Intellia Therapeutics' Cash, Cash Equivalents And Marketable Securities Of $1B,...
02-22 08:38